Manufacturers are investing in next-generation stent technologies — including bioresorbable scaffolds, polymer-free drug-eluting stents, and improved delivery systems — aiming to reduce long-term complications, restenosis, and need for repeat interventions. These developments underscore importance of US Percutaneous Coronary Intervention Market Key Manufacturers in shaping the...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek